Strive Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-923
Closed -$260K 4
2025
Q3
$260K Sell
923
-221
-19% -$64.1K 0.14% 69
2025
Q2
$319K Sell
1,144
-1,268
-53% -$359K 0.19% 64
2025
Q1
$751K Sell
2,412
-90
-4% -$26.6K 0.52% 46
2024
Q4
$652K Buy
+2,502
New +$742K 0.49% 57

Other funds holding AMGN

Strive Asset Management's AMGN Position: Q4 2025 in Review

Strive Asset Management sold out of Amgen (AMGN) in Q4 2025, closing a stake of 923 shares — an estimated $260K sold.

Strive Asset Management first reported a position in AMGN in Q4 2024 and held it in 4 quarters. The position peaked at $751K in Q1 2025. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Strive Asset Management reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Strive Asset Management sold 923 Amgen shares in Q4 2025, an estimated $260K.
  • Strive Asset Management first reported a position in Amgen in Q4 2024 and held it in 4 quarters.
  • Strive Asset Management's Amgen position peaked at $751K in Q1 2025.
  • 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Strive Asset Management's 13F filing for Q4 2025.